Thursday, June 11, 2026
🇺🇸 FDA

Patent directory · USPTO A61K / A61P

Browse patents

Browse 30,257 pharma-relevant patents (US A61K/A61P) linked to tracked companies, drugs, and pipeline programs.

Patents indexed 30,257
Companies 1,769
Drugs linked 4,797

Quick answer

NovaPharmaNews indexes 30,257 US pharmaceutical patents from USPTO PatentsView (CPC A61K/A61P), cross-linked to company assignees, drug INN profiles, and pipeline programs. Search by patent number, applicant, title, or CPC code — or use facet hubs for expiring patents, assignees, and therapeutic areas.

Patent results

Page 49 of 1,261

  1. US 12274696

    Methods of administering nalbuphine

    Trevi Therapeutics, Inc. · Granted Apr 15, 2025 · Expires Apr 10, 2045

    granted

  2. US 12275786

    Anti-thyroglobulin t cell receptors

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Apr 15, 2025 · Expires Apr 10, 2045

    granted

  3. US 12274759

    Affibody proteins specific for B7-H3 (CD276)

    Regents of the University of Minnesota · Granted Apr 15, 2025 · Expires Apr 10, 2045

    granted

  4. US 12275957

    Next generation designer liver organoids and their methods of preparation and use

    ARIZONA BOARD OF REGENTS FOR AND ON BEHALF OF ARIZONA STATE UNIVERSITY · Granted Apr 15, 2025 · Expires Apr 10, 2045

    granted

  5. US 12274684

    Treatment of vasculopathy with prostacyclin and mesenchymal stem cells

    United Therapeutics Corporation · Granted Apr 15, 2025 · Expires Apr 10, 2045

    granted

  6. US 12275937

    Stereospecific linkages in RNA editing oligonucleotides

    ProQR Therapeutics II B.V. · Granted Apr 15, 2025 · Expires Apr 10, 2045

    granted

  7. US 12275684

    Methods for making and using endoxifen

    ATOSSA THERAPEUTICS, INC. · Granted Apr 15, 2025 · Expires Apr 10, 2045

    granted

  8. US 12274741

    Cattle fever tick-infestation vaccines and uses thereof

    The United States of America, as represented by the Secretary of Agriculture · Granted Apr 15, 2025 · Expires Apr 10, 2045

    granted

  9. US 12275940

    Conjugated antisense compounds and their use

    Ionis Pharmaceuticals, Inc. · Granted Apr 15, 2025 · Expires Apr 10, 2045

    granted

  10. US 12274735

    IL-4-fusion formulations for treatment of central nervous system (CNS) tumors

    Medicenna Therapeutics Inc. · Granted Apr 15, 2025 · Expires Apr 10, 2045

    granted

  11. US 12275769

    Activatable interleukin 12 polypeptides and methods of use thereof

    Werewolf Therapeutics, Inc. · Granted Apr 15, 2025 · Expires Apr 10, 2045

    granted

  12. US 12274725

    Zika virus strains for treatment of glioma

    The Board of Regents of the University of Texas System · Granted Apr 15, 2025 · Expires Apr 10, 2045

    granted

  13. US 12274710

    Compound for regulating body weight imbalance, composition thereof and application thereof

    GUANGZHOU CENTURY CLINICAL RESEARCH CO., LTD · Granted Apr 15, 2025 · Expires Apr 10, 2045

    granted

  14. US 12275955

    Combining iPSC derived effector cell types for immunotherapy use

    Fate Therapeutics, Inc. · Granted Apr 15, 2025 · Expires Apr 10, 2045

    granted

  15. US 12275781

    Monoclonal antibodies against MHC-bound human dickkopf-1 peptides and uses thereof

    The Board of Regents of the University of Texas System · Granted Apr 15, 2025 · Expires Apr 10, 2045

    granted

  16. US 12275966

    Genetically engineered cells

    The Regents of the University of California · Granted Apr 15, 2025 · Expires Apr 10, 2045

    granted

  17. US 12270814

    Kits and methods for prediction and treatment of preeclampsia

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Apr 8, 2025 · Expires Apr 3, 2045

    granted

  18. US 12269872

    Neutralizing antibodies to Plasmodium falciparum circumsporozoite protein and their use

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Apr 8, 2025 · Expires Apr 3, 2045

    granted

  19. US 12269858

    Activin receptor type IIB variants and methods of use thereof

    Keros Therapeutics, Inc. · Granted Apr 8, 2025 · Expires Apr 3, 2045

    granted

  20. US 12270050

    Human T cell derived from T cell-derived induced pluripotent stem cell and methods of making and using

    Regents of the University of Minnesota · Granted Apr 8, 2025 · Expires Apr 3, 2045

    granted

  21. US 12269803

    Krüppel-like factor 15 (KLF15) small molecule agonists in kidney disease

    United States Government as represented by the Department of Veterans Affairs · Granted Apr 8, 2025 · Expires Apr 3, 2045

    granted

  22. US 12269856

    Hepcidin analogues and uses thereof

    Protagonist Therapeutics, Inc. · Granted Apr 8, 2025 · Expires Apr 3, 2045

    granted

  23. US 12270080

    NcRNA and uses thereof

    THE REGENTS OF THE UNIVERSITY OF MICHIGAN · Granted Apr 8, 2025 · Expires Apr 3, 2045

    granted

  24. US 12269801

    Modified amino acids

    Sutro Biopharma, Inc. · Granted Apr 8, 2025 · Expires Apr 3, 2045

    granted

Frequently asked questions

What patents are included in this directory?

We index 30,257 published US pharma-relevant patents filtered to CPC classes A61K and A61P, with assignee links to our company directory where a match exists.

How do I search for a patent?

Use the search box to match patent number, title, applicant name, or CPC classification (e.g. A61K). For cross-entity queries spanning news and drugs, use the global search.

How is this different from the patent intelligence dashboard?

The dashboard at /patents highlights expirations, recent grants, and assignee rankings. Browse is the full paginated directory with search — best for looking up a specific filing or applicant portfolio slice.

Drug approvals, clinical trials, M&A, event intelligence, and company updates — weekly.

Customize topics & region
Topics
Region

No spam. Unsubscribe anytime. See our privacy policy.